跳至主要内容
临床试验/IRCT20171011036717N1
IRCT20171011036717N1招募中2 期

Comparison effectiveness of Levetiracetam and Sodium Valproate in prevention of Migraine without aura

Vice chancellor for Research, Ardabil University of Medical Sciences0 个研究点目标入组 100 人开始时间: 待定最近更新:
适应症

试验速览

阶段
2 期
状态
招募中
发起方
入组人数
100

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
16 years 至 65 years(—)
性别
All

入选标准

  • The age of 16 to 65 years old who will be candidate to achieve prophylaxis of migraine by being diagnosed with migraine headaches.
  • pregnancy and lactation
  • liver failure
  • kidney failure
  • sedative medication
  • non-migraine headaches

排除标准

  • Exlusion criteria: pregnancy and lactation; liver and kidney failure; sedative medication; being smoker; non-migraine headaches.

研究者

发起方
Vice chancellor for Research, Ardabil University of Medical Sciences

相似试验